750529
Last Update Posted: 2014-07-08
Recruiting has ended
All Genders accepted | 65 Years + |
15 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Alzheimer and Sleep
The aim of the study is the analysis of two inhibitors of Ach-E: galantamine and donépézil in over 65 years' old patients suffering from Alzheimer disease (MMSE between 20 and 26) without Alzheimer's medication.
Feasibility study, open, randomized, controlled, cross-over study in 65 years old patients.
Eligibility
Relevant conditions:
Alzheimer's Disease
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov